Granite Group Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ECSS
ATO
Granite Group Advisors's ABBV Position: Q2 2026 in Review
Granite Group Advisors increased its AbbVie (ABBV) stake by 0.25% in Q2 2026, buying an estimated $2.15K and bringing the position to 3,947 shares worth $993K. The position accounts for 0.59% of the portfolio, ranked #33.
Granite Group Advisors first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.15M in Q1 2024. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Granite Group Advisors held 3,947 shares of AbbVie worth $993K as of Q2 2026.
- Granite Group Advisors bought 10 AbbVie shares in Q2 2026, an estimated $2.15K.
- AbbVie made up 0.59% of Granite Group Advisors's portfolio in Q2 2026, its #33 holding.
- Granite Group Advisors first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
- Granite Group Advisors's AbbVie position peaked at $2.15M in Q1 2024.
- 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Granite Group Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.